The Business of Fashion
Agenda-setting intelligence, analysis and advice for the global fashion community.
Agenda-setting intelligence, analysis and advice for the global fashion community.
TOKYO, Japan — US healthcare conglomerate Johnson & Johnson said on Tuesday it is acquiring all outstanding shares of Japanese skincare firm Ci:z Holdings Co Ltd that it does not already own for 230 billion yen ($2.05 billion) in cash.
J&J is betting the deal, which will give it ownership of the Japanese firm's popular brands such as Dr.Ci:Labo, Labo Labo and Genomer line of skincare products, will help it strengthen its international innovation pipeline.
It will pay 5,900 yen per Ci:z share, a 55 percent premium over Tuesday's closing price, and also acquire the shares owned by the Japanese firm's founder Yoshinori Shirono, J&J said in a statement.
CIC Corp, the ownership vehicle of the founder, is the top shareholder of Ci:z with a 27.96 percent interest, according to Refinitiv data.
ADVERTISEMENT
J&J is the second largest shareholder of the Japanese firm and owns a 19.9 percent stake through its affiliate.
J&J, which has been selling off certain businesses such as diabetes care devices to focus on better performing units and development of new products, plans to launch the tender offer on Oct. 29.
By Makiko Yamazaki and Chris Gallagher; editors: Miyoung Kim and Muralikumar Anantharaman.
From analysis of the global fashion and beauty industries to career and personal advice, BoF’s founder and CEO, Imran Amed, will be answering your questions on Sunday, February 18, 2024 during London Fashion Week.
The State of Fashion 2024 breaks down the 10 themes that will define the industry in the year ahead.
Imran Amed reviews the most important fashion stories of the year and shares his predictions on what this means for the industry in 2024.
After three days of inspiring talks, guests closed out BoF’s gathering for big thinkers with a black tie gala followed by an intimate performance from Rita Ora — guest starring Billy Porter.